We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+6.97%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$977M
AUM Growth
+$61.2M
Cap. Flow
+$15.6M
Cap. Flow %
1.6%
Top 10 Hldgs %
35.78%
Holding
149
New
31
Increased
28
Reduced
46
Closed
17

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$17.7M
2
DELL icon
Dell
DELL
+$17.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$15.1M
4
PLGO
Pelagos Insurance Capital
PLGO
+$11.1M
5
CI icon
Cigna
CI
+$9.9M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$16M
2
LLY icon
Eli Lilly
LLY
+$15.2M
3
MSFT icon
Microsoft
MSFT
+$14M
4
UNH icon
UnitedHealth
UNH
+$11.2M
5
AAPL icon
Apple
AAPL
+$10.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.48%
2 Technology 20.72%
3 Healthcare 12.89%
4 Industrials 12%
5 Communication Services 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHC icon
126
Acadia Healthcare
ACHC
$2.55B
$294K 0.03%
4,640
-4,700
-50% -$339K
HUM icon
127
Humana
HUM
$47.6B
$260K 0.03%
820
– –
BMRN icon
128
BioMarin Pharmaceuticals
BMRN
$12.5B
$252K 0.03%
3,580
– –
ITCI
129
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$249K 0.03%
3,400
– –
CCRN
130
DELISTED
Cross Country Healthcare
CCRN
$214K 0.02%
+15,900
New +$234K
AMN icon
131
AMN Healthcare
AMN
$1.32B
$203K 0.02%
+4,800
New +$252K
PL icon
132
Planet Labs
PL
$5.83B
$139K 0.01%
62,300
-81,038
-57% -$180K
ACLX
133
DELISTED
Arcellx
ACLX
– –
-4,800
Closed -$265K
ARCO icon
134
Arcos Dorados Holdings
ARCO
$1.64B
– –
-116,481
Closed -$1.05M
BIIB icon
135
Biogen
BIIB
$31.9B
– –
-42,800
Closed -$9.92M
CRSP icon
136
CRISPR Therapeutics
CRSP
$5.01B
– –
-20,939
Closed -$1.13M
GIS icon
137
General Mills
GIS
$19.6B
– –
-35,600
Closed -$2.25M
GTLS
138
DELISTED
Chart Industries
GTLS
– –
-8,666
Closed -$1.25M
HOS
139
Hornbeck Offshore Services, Inc.
HOS
$2.89B
– –
-102,869
Closed -$1.23M
HOLX
140
DELISTED
Hologic
HOLX
– –
-7,160
Closed -$532K
INSW icon
141
International Seaways
INSW
$5.34B
– –
-170,850
Closed -$10.1M
LRCX icon
142
Lam Research
LRCX
$339B
– –
-28,920
Closed -$3.08M
MRK icon
143
Merck
MRK
$355B
– –
-129,503
Closed -$16M
NKE icon
144
Nike
NKE
$53.7B
– –
-4,800
Closed -$362K
ONON icon
145
On Holding
ONON
$8.94B
– –
-12,745
Closed -$495K
SBUX icon
146
Starbucks
SBUX
$110B
– –
-14,393
Closed -$1.12M
RDDT icon
147
Reddit
RDDT
$30.7B
– –
-130,218
Closed -$8.32M
INFN
148
DELISTED
Infinera Corporation Common Stock
INFN
– –
-40,800
Closed -$248K
NARI
149
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-24,234
Closed -$1.17M
2 3 4 5
6

Similar funds

ACG
Allen Capital Group Grand Island, Nebraska $1.23B AUM 19.04% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CCFCSB
Cape Cod Five Cents Savings Bank Orleans, Massachusetts $1.23B AUM
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
OA
Oxbow Advisors Austin, Texas $1.23B AUM 23.59% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.23B AUM 15.23% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return
WVUF
West Virginia University Foundation Morgantown, West Virginia $1.22B AUM 21.82% 1-Year Est. Return

Clough Capital Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Clough Capital Partners held 149 positions worth $977M, up 6.7% from $916M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Clough Capital Partners's Q3 2024 filing shows 31 new, 28 increased, 46 reduced and 17 closed positions. Its largest new stake was Bristol-Myers Squibb: 376,952 shares worth $19.5M. The largest sale was Merck, an estimated $16M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Clough Capital Partners's largest Q3 2024 buy was Bristol-Myers Squibb: 376,952 shares worth $19.5M.
  • Clough Capital Partners added most to Dell in Q3 2024, an estimated $17.1M increase.
  • Clough Capital Partners's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $15.2M.
  • Clough Capital Partners fully exited Merck in Q3 2024, selling an estimated $16M.
  • Clough Capital Partners's ten largest holdings make up 36% of its $977M portfolio in Q3 2024.
  • Clough Capital Partners opened 31 new positions and closed 17 in Q3 2024.
  • Clough Capital Partners's portfolio value rose 6.7% quarter-over-quarter to $977M.

Based on Clough Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.